President-elect Donald Trump has put forward a formal pick for the top spot at the U.S. Food and Drug Administration. As ...

New York-based health comms agency Calcium+Company is living up to its name, strengthening the bones of its business with the ...

For many biopharmas, it takes years of hard work to transition from being a clinical-stage drugmaker to a commercial one.

While Johnson & Johnson hopes to soon resolve more than 60,000 talc lawsuits with an $8 billion bankruptcy settlement in the ...

For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...

While president-elect Donald Trump has already made his leadership picks for the Department of Health and Human Services (HHS ...

As the biopharma industry braces for a second term under President-elect Donald Trump, speculation is swirling around the ...

Few pharmaceutical products have taken the market by storm like Roche’s Vabysmo. | Interim results from a late-stage trial of ...

The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...

As a council of outside experts prepares to meet Thursday to discuss AstraZeneca’s Andexxa, the FDA has flagged “major safety ...

As he introduced Novartis’ meet-the-management event Thursday in London, CEO Vas Narasimhan hammered home Novartis’ status as ...

Johnson & Johnson and Merck are laying off workers in China, according to a story from Bloomberg which cites reports from ...